Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Rheumatology Reviews
  4. Volume 21, Issue 1
  5. Article
Volume 21, Issue 1
  • ISSN: 1573-3971
  • E-ISSN: 1875-6360

Abstract

Rheumatoid Arthritis (RA) is a progressive autoimmune condition inflicting serious threats to people’s life and health by causing severe pain and joint destruction. It affects not only bones and joints but also causes comorbid conditions and shortens the lifetime. The interactions and synergistic effects of comorbid disease with RA are not yet well studied. Hence, understanding how these conditions will collectively affect the progression and outcome of RA is the current area of research. Identification of RA and comorbidities associated with target genes may uncover diagnosis and treatment methodologies. This review is to provide an overview of the interlinking approach of Rheumatoid Arthritis with its comorbid conditions and its systemic complications using bioinformatic techniques which would be useful to identify the genes and pathways that are in common for both RA and comorbid diseases. It would also emphasize the significance of bioinformatics in comparing the pathological features of RA and comorbid diseases. With the help of bioinformatics, valuable insights into the mechanism underlying Rheumatoid arthritis and comorbid diseases would be better understood.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/crr/10.2174/0115733971302188240515075547
2024-05-27
2025-05-30

  • From This Site

    /content/journals/crr/10.2174/0115733971302188240515075547
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. McInnesI. B. SchettG. The pathogenesis of rheumatoid arthritis.N Engl J Med2011365232205221910.1056/NEJMra1004965
     [Google Scholar]
  2. AlamanosY. VoulgariP.V. DrososA.A. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: A systematic review.Semin. Arthritis Rheum.200636318218810.1016/j.semarthrit.2006.08.00617045630
     [Google Scholar]
  3. BaconsP.A. KitasG.D. The significance of vascular inflammation in rheumatoid arthritis.Ann. Rheum. Dis.1994531062162310.1136/ard.53.10.6217979572
     [Google Scholar]
  4. van OnnaM. BoonenA. The challenging interplay between rheumatoid arthritis, ageing and comorbidities.BMC Musculoskelet. Disord.201617118410.1186/s12891‑016‑1038‑327118031
     [Google Scholar]
  5. ZafariP. GolpourM. HafeziN. BashashD. EsmaeiliS.A. TavakoliniaN. RafieiA. Tuberculosis comorbidity with rheumatoid arthritis: Gene signatures, associated biomarkers, and screening.IUBMB Life2021731263910.1002/iub.241333217772
     [Google Scholar]
  6. GabrielS.E. MichaudK. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases.Arthritis Res. Ther.200911322910.1186/ar266919519924
     [Google Scholar]
  7. CibereJ. SibleyJ. HagaM. Rheumatoid arthritis and the risk of malignancy.Arthritis Rheum.19974091580158610.1002/art.17804009069324011
     [Google Scholar]
  8. MitchellD.M. FriesJ.F. An analysis of the american rheumatism association criteria for rheumatoid arthritis.Arthritis Rheum.198225548148710.1002/art.17802505017082397
     [Google Scholar]
  9. BakerG.L. KahlL.E. ZeeB.C. StolzerB.L. AgarwalA.K. MedsgerT.A.Jr Malignancy following treatment of rheumatoid arthritis with cyclophosphamide.Am. J. Med.19878311910.1016/0002‑9343(87)90490‑63605161
     [Google Scholar]
  10. FazeliM.S. KhaychukV. WittstockK. HanX. CrocketG. LinM. HillS.L. FerriL. Rheumatoid arthritis-associated interstitial lung disease: Epidemiology, risk/prognostic factors, and treatment landscape.Clin. Exp. Rheumatol.20213951108111810.55563/clinexprheumatol/h9tc5733635222
     [Google Scholar]
  11. IqbalK. KellyC. Treatment of rheumatoid arthritis-associated interstitial lung disease: A perspective review.Ther. Adv. Musculoskelet. Dis.20157624726710.1177/1759720X1561225026622326
     [Google Scholar]
  12. RoubilleC. HaraouiB. Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: A systematic literature review.Semin. Arthritis Rheum.201443561362610.1016/j.semarthrit.2013.09.00524231065
     [Google Scholar]
  13. HeY. LiM. YuH. YinF. ZhangX. YangQ. XieX. WeiG. ChenH. HeC. HeY. ChenJ. Bibliometric and altmetric analysis of research relating to antiphospholipid syndrome based on VOS viewer (2011–2021).Clin. Rheumatol.20234251285129510.1007/s10067‑022‑06485‑536604357
     [Google Scholar]
  14. HuH. TangN. ZhangF. LiL. LiL. Bioinformatics and system biology approach to identify the influences of COVID-19 on rheumatoid arthritis.Front. Immunol.20221386067610.3389/fimmu.2022.86067635464423
     [Google Scholar]
  15. BardouP. MarietteJ. EscudiéF. DjemielC. KloppC. jvenn: an interactive Venn diagram viewer.BMC Bioinformatics201415129310.1186/1471‑2105‑15‑29325176396
     [Google Scholar]
  16. ViechtbauerW. Conducting Meta-Analyses in R with the metafor Package.J. Stat. Softw.201036314810.18637/jss.v036.i03
     [Google Scholar]
  17. KardeşS. KuzuA.S. RaikerR. PakhchanianH. KaragülleM. Public interest in rheumatic diseases and rheumatologist in the United States during the COVID-19 pandemic: Evidence from Google Trends.Rheumatol. Int.202141232933410.1007/s00296‑020‑04728‑933070255
     [Google Scholar]
  18. RaikerR. DeYoungC. PakhchanianH. AhmedS. KavadichandaC. GuptaL. KardeşS. Outcomes of COVID-19 in patients with rheumatoid arthritis: A multicenter research network study in the United States.Semin. Arthritis Rheum.20215151057106610.1016/j.semarthrit.2021.08.01034450504
     [Google Scholar]
  19. MahmudS.M.H. Al-MustanjidM. AkterF. RahmanM.S. AhmedK. RahmanM.H. ChenW. MoniM.A. Bioinformatics and system biology approach to identify the influences of SARS- CoV-2 infections to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease patients.Brief. Bioinform.2021225bbab11510.1093/bib/bbab11533847347
     [Google Scholar]
  20. Bin JooY. LimY.H. KimK.J. ParkK.S. ParkY.J. Respiratory viral infections and the risk of rheumatoid arthritis.Arthritis Res. Ther.20192111810.1186/S13075‑019‑1977‑9/TABLES/330606217
     [Google Scholar]
  21. SolomonJ.J. RyuJ.H. TazelaarH.D. MyersJ.L. TuderR. CoolC.D. Curran-EverettD. FischerA. SwigrisJ.J. BrownK.K. Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD).Respir. Med.201310781247125210.1016/j.rmed.2013.05.00223791462
     [Google Scholar]
  22. QiuY. LiuC. ShiY. HaoN. TanW. WangF. Integrating bioinformatic resources to identify characteristics of rheumatoid arthritis-related usual interstitial pneumonia.BMC Genomics202324145010.1186/s12864‑023‑09548‑237563706
     [Google Scholar]
  23. NakamuraY. SudaT. KaidaY. KonoM. HozumiH. HashimotoD. EnomotoN. FujisawaT. InuiN. ImokawaS. YasudaK. ShiraiT. SuganumaH. MoritaS. HayakawaH. TakeharaY. ColbyT.V. ChidaK. Rheumatoid lung disease: Prognostic analysis of 54 biopsy-proven cases.Respir. Med.201210681164116910.1016/j.rmed.2012.04.00422560113
     [Google Scholar]
  24. Rheumatoid Arthritis-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis: Shared Mechanistic and Phenotypic Traits Suggest Overlapping Disease Mechanisms Revista de Investigación Clínica. Available from: https://clinicalandtranslationalinvestigation.com/abstract.php?id=58 (Accessed: Nov. 29, 2023).
  25. JuarezM.M. ChanA.L. NorrisA.G. MorrisseyB.M. AlbertsonT.E. Acute exacerbation of idiopathic pulmonary fibrosis-a review of current and novel pharmacotherapies.J. Thorac. Dis.20157349951910.3978/J.ISSN.2072‑1439.2015.01.1725922733
     [Google Scholar]
  26. KimE.J. ElickerB.M. MaldonadoF. WebbW.R. RyuJ.H. Van UdenJ.H. LeeJ.S. KingT.E.Jr CollardH.R. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease.Eur. Respir. J.20103561322132810.1183/09031936.0009230919996193
     [Google Scholar]
  27. ElkingtonP. TebrueggeM. MansourS. Tuberculosis: An infection-initiated autoimmune disease?Trends Immunol.2016371281581810.1016/j.it.2016.09.00727773684
     [Google Scholar]
  28. MalaviyaA. KotwalP.P. Arthritis associated with tuberculosis.Best Pract. Res. Clin. Rheumatol.200317231934310.1016/S1521‑6942(02)00126‑212787528
     [Google Scholar]
  29. BadrM.T. HäckerG. Gene expression profiling meta-analysis reveals novel gene signatures and pathways shared between tuberculosis and rheumatoid arthritis.PLoS One2019143e021347010.1371/journal.pone.021347030845171
     [Google Scholar]
  30. ShenT-C. LinC-L. WeiC-C. ChenC-H. TuC-Y. HsiaT-C. ShihC-M. HsuW-H. ChungC-J. SungF-C. KaoC-H. Previous history of tuberculosis is associated with rheumatoid arthritis.Int. J. Tuberc. Lung Dis.201519111401140510.5588/ijtld.15.005726467595
     [Google Scholar]
  31. ElkayamO. SegalR. LidgiM. CaspiD. Positive anti-cyclic citrullinated proteins and rheumatoid factor during active lung tuberculosis.Ann. Rheum. Dis.20066581110111210.1136/ard.2005.04522916361276
     [Google Scholar]
  32. KakumanuP. YamagataH. SobelE.S. ReevesW.H. ChanE.K.L. SatohM. Patients with pulmonary tuberculosis are frequently positive for anti–cyclic citrullinated peptide antibodies, but their sera also react with unmodified arginine-containing peptide.Arthritis Rheum.20085861576158110.1002/art.2351418512773
     [Google Scholar]
  33. SmolenJ.S. SteinerG. Therapeutic strategies for rheumatoid arthritis.Nat. Rev. Drug Discov.20032647348810.1038/nrd110912776222
     [Google Scholar]
  34. KanagawaH. NikiY. KobayashiT. SatoY. KatsuyamaE. FujieA. HaoW. MiyamotoK. TandoT. WatanabeR. MoritaM. MoriokaH. MatsumotoM. ToyamaY. MiyamotoT. Mycobacterium tuberculosis promotes arthritis development through toll-like receptor 2.J. Bone Miner. Metab.201533213514110.1007/s00774‑014‑0575‑924633489
     [Google Scholar]
  35. KobayashiT. YoshieH. Host responses in the link between periodontitis and rheumatoid arthritis.Curr. Oral Health Rep.2015211810.1007/s40496‑014‑0039‑225657893
     [Google Scholar]
  36. PotempaJ. MydelP. KozielJ. The case for periodontitis in the pathogenesis of rheumatoid arthritis.Nat. Rev. Rheumatol.2017131060662010.1038/nrrheum.2017.13228835673
     [Google Scholar]
  37. LiS. ZhouC. XuY. WangY. LiL. PelekosG. ZiebolzD. SchmalzG. QinZ. Similarity and potential relation between periimplantitis and Rheumatoid arthritis on transcriptomic level: Results of a bioinformatics study.Front. Immunol.20211270266110.3389/fimmu.2021.70266134858391
     [Google Scholar]
  38. de PabloP. DietrichT. McAlindonT.E. Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population.J. Rheumatol.2008351707618050377
     [Google Scholar]
  39. RosensteinE.D. GreenwaldR.A. KushnerL.J. WeissmannG. Hypothesis: the humoral immune response to oral bacteria provides a stimulus for the development of rheumatoid arthritis.Inflammation200428631131810.1007/s10753‑004‑6641‑z16245073
     [Google Scholar]
  40. HashimotoH. HashimotoS. ShimazakiY. Relationship between tooth loss and the medications used for the treatment of Rheumatoid arthritis in japanese patients with rheumatoid arthritis: A cross-sectional study.J Clin Med202110487610.3390/jcm10040876
     [Google Scholar]
  41. de Oliveira FerreiraR. de Brito SilvaR. MagnoM.B. Carvalho AlmeidaA.P.C.P.S. FagundesN.C.F. MaiaL.C. LimaR.R. Does periodontitis represent a risk factor for rheumatoid arthritis? A systematic review and meta-analysis.Ther. Adv. Musculoskelet. Dis.2019111759720X198585110.1177/1759720X1985851431316593
     [Google Scholar]
  42. KrennmairG. SeemannR. PiehslingerE. Dental implants in patients with Rheumatoid arthritis: clinical outcome and peri-implant findings.J. Clin. Periodontol.2010371092893610.1111/j.1600‑051X.2010.01606.x20718894
     [Google Scholar]
  43. Rodríguez-LozanoB. González-FeblesJ. Garnier-RodríguezJ.L. DadlaniS. Bustabad-ReyesS. SanzM. Sánchez-AlonsoF. Sánchez-PiedraC. González-DávilaE. Díaz-GonzálezF. Association between severity of periodontitis and clinical activity in Rheumatoid arthritis patients: A case–control study.Arthritis Res. Ther.20192112710.1186/s13075‑019‑1808‑z30658685
     [Google Scholar]
  44. RashidT. EbringerA. Autoimmunity in rheumatic diseases is induced by microbial infections via crossreactivity or molecular mimicry.Autoimmune Dis.2012201211910.1155/2012/53928222454761
     [Google Scholar]
  45. ZhangX. ZhangD. JiaH. FengQ. WangD. LiangD. WuX. LiJ. TangL. LiY. LanZ. ChenB. LiY. ZhongH. XieH. JieZ. ChenW. TangS. XuX. WangX. CaiX. LiuS. XiaY. LiJ. QiaoX. Al-AamaJ.Y. ChenH. WangL. WuQ. ZhangF. ZhengW. LiY. ZhangM. LuoG. XueW. XiaoL. LiJ. ChenW. XuX. YinY. YangH. WangJ. KristiansenK. LiuL. LiT. HuangQ. LiY. WangJ. The oral and gut microbiomes are perturbed in Rheumatoid arthritis and partly normalized after treatment.Nat. Med.201521889590510.1038/nm.391426214836
     [Google Scholar]
  46. ClementeJ.C. UrsellL.K. ParfreyL.W. KnightR. The impact of the gut microbiota on human health: An integrative view.Cell201214861258127010.1016/j.cell.2012.01.03522424233
     [Google Scholar]
  47. LiuX. ZouQ. ZengB. FangY. WeiH. Analysis of fecal Lactobacillus community structure in patients with early Rheumatoid arthritis.Curr. Microbiol.201367217017610.1007/s00284‑013‑0338‑123483307
     [Google Scholar]
  48. Mena-VázquezN. Ruiz-LimónP. Moreno-IndiasI. Manrique-ArijaS. Lisbona-MontañezJ.M. RiojaJ. MucientesA. Martin-NúñezG.M. Cano-GarcíaL. TinahonesF.J. Fernández-NebroA. Adiposity is associated with expansion of the genus Dialister in Rheumatoid arthritis patients.Biomed. Pharmacother.202316011438811438810.1016/j.biopha.2023.11438836773522
     [Google Scholar]
  49. Mena-VázquezN. Postprandial Hyperlipidemia: Association with inflammation and subclinical atherosclerosis in patients with Rheumatoid arthritis.Biomedicines202210113310.3390/biomedicines10010133
     [Google Scholar]
  50. Manrique-ArijaS. Mena-VazquezN. UreñaI. RiojaJ. ValdivielsoP. Ginel-MendozaL. Abad-SánchezS. Jiménez-NúñezF.G. Oliver-MartosB. Fernandez-NebroA. Cumulative inflammatory burden and obesity as determinants of insulin resistance in patients with established Rheumatoid arthritis: Cross-sectional study.BMJ Open2021112e04474910.1136/bmjopen‑2020‑04474933563625
     [Google Scholar]
  51. OhnoT. AuneD. HeathA. K. Adiposity and the risk of Rheumatoid arthritis: A systematic review and meta-analysis of cohort studies.Sci Rep20201011600610.1038/s41598‑020‑71676‑6
     [Google Scholar]
  52. LuB. HirakiL.T. SparksJ.A. MalspeisS. ChenC.Y. AwosogbaJ.A. ArkemaE.V. CostenbaderK.H. KarlsonE.W. Being overweight or obese and risk of developing Rheumatoid arthritis among women: A prospective cohort study.Ann. Rheum. Dis.201473111914192210.1136/annrheumdis‑2014‑20545925057178
     [Google Scholar]
  53. KalinkovichA. LivshitsG. A cross talk between dysbiosis and gut-associated immune system governs the development of inflammatory arthropathies.Semin. Arthritis Rheum.201949347448410.1016/j.semarthrit.2019.05.00731208713
     [Google Scholar]
  54. KarpouzasG.A. MalpesoJ. ChoiT.Y. LiD. MunozS. BudoffM.J. Prevalence, extent and composition of coronary plaque in patients with Rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease.Ann. Rheum. Dis.201473101797180410.1136/annrheumdis‑2013‑20361723887286
     [Google Scholar]
  55. ZhangS. NiuQ. TongL. LiuS. WangP. XuH. LiB. ZhangH. Identification of the susceptible genes and mechanism underlying the comorbid presence of coronary artery disease and Rheumatoid arthritis: A network modularization analysis.BMC Genomics202324141110.1186/s12864‑023‑09519‑737474895
     [Google Scholar]
  56. Rheumatoid arthritis complicates noninvasive whole blood gene expression testing for coronary artery disease - EM consulte.Available from: https://www.em-consulte.com/article/1143585/figures/rheumatoid-arthritis-complicates-noninvasive-whole (Accessed: Nov. 29, 2023).
  57. KitasG.D. ErbN. Tackling ischaemic heart disease in Rheumatoid arthritis.Br. J. Rheumatol.200342560761310.1093/rheumatology/keg17512709534
     [Google Scholar]
  58. WangH. LiX. GongG. Cardiovascular outcomes in patients with co-existing coronary artery disease and Rheumatoid arthritis.Medicine20209914e1965810.1097/MD.000000000001965832243398
     [Google Scholar]
  59. MeuneC. TouzéE. TrinquartL. AllanoreY. Trends in cardiovascular mortality in patients with Rheumatoid arthritis over 50 years: A systematic review and meta-analysis of cohort studies.Rheumatology (Oxford)200948101309131310.1093/rheumatology/kep25219696061
     [Google Scholar]
  60. KremersH.M. CrowsonC.S. TherneauT.M. RogerV.L. GabrielS.E. High ten-year risk of cardiovascular disease in newly diagnosed Rheumatoid arthritis patients: A population-based cohort study.Arthritis Rheum.20085882268227410.1002/art.2365018668561
     [Google Scholar]
  61. CrowsonC.S. LiaoK.P. DavisJ.M.III SolomonD.H. MattesonE.L. KnutsonK.L. HlatkyM.A. GabrielS.E. Rheumatoid arthritis and cardiovascular disease.Am. Heart J.20131664622628.e110.1016/j.ahj.2013.07.01024093840
     [Google Scholar]
  62. Avina-ZubietaJ.A. ThomasJ. SadatsafaviM. LehmanA.J. LacailleD. Risk of incident cardiovascular events in patients with Rheumatoid arthritis: A meta-analysis of observational studies.Ann. Rheum. Dis.20127191524152910.1136/annrheumdis‑2011‑20072622425941
     [Google Scholar]
  63. SolomonD.H. CurhanG.C. RimmE.B. CannuscioC.C. KarlsonE.W. Cardiovascular risk factors in women with and without Rheumatoid arthritis.Arthritis Rheum.200450113444344910.1002/art.2063615529391
     [Google Scholar]
  64. SolomonD.H. KarlsonE.W. RimmE.B. CannuscioC.C. MandlL.A. MansonJ.E. StampferM.J. CurhanG.C. Cardiovascular morbidity and mortality in women diagnosed with Rheumatoid arthritis.Circulation200310791303130710.1161/01.CIR.0000054612.26458.B212628952
     [Google Scholar]
  65. TianZ. MclaughlinJ. VermaA. ChinoyH. HealdA.H. The relationship between Rheumatoid arthritis and diabetes mellitus: A systematic review and meta-analysis.Cardiovasc. Endocrinol. Metab.202110212513110.1097/XCE.000000000000024434124603
     [Google Scholar]
  66. RuscittiP. UrsiniF. CiprianiP. CicciaF. LiakouliV. CarubbiF. GugginoG. BerardicurtiO. GrembialeR. TrioloG. De SarroG. GiacomelliR. Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by Rheumatoid arthritis.Medicine20179634e789610.1097/MD.000000000000789628834907
     [Google Scholar]
  67. VermaA.K. BhattD. GoyalY. DevK. BegM.M.A. AlsahliM.A. RahmaniA.H. Association of Rheumatoid arthritis with diabetic comorbidity: Correlating accelerated insulin resistance to inflammatory responses in patients.J. Multidiscip. Healthc.20211480982010.2147/JMDH.S28546933880030
     [Google Scholar]
  68. LiewT.O. MishraR. LahiriC. Comorbidity network analyses of global Rheumatoid arthritis and type 2 diabetes reveal IL2 & IL6 as common role players. RojasI. ValenzuelaO. RojasF. HerreraL. Bioinformatics and Biomedical Engineering. IWBBIO 2020. Lecture Notes in Computer ScienceSpringerCham20201210822723610.1007/978‑3‑030‑45385‑5_21
     [Google Scholar]
  69. SolomonD.H. LoveT.J. CanningC. SchneeweissS. Risk of diabetes among patients with Rheumatoid arthritis, psoriatic arthritis and psoriasis.Ann. Rheum. Dis.201069122114211710.1136/ard.2009.12547620584807
     [Google Scholar]
  70. LuM.C. YanS.T. YinW.Y. KooM. LaiN.S. Risk of Rheumatoid arthritis in patients with type 2 diabetes: A nationwide population-based case-control study.PLoS One201497e10152810.1371/journal.pone.010152824988532
     [Google Scholar]
  71. GilesJ.T. DanielidesS. SzkloM. PostW.S. BlumenthalR.S. PetriM. SchreinerP.J. BudoffM. DetranoR. BathonJ.M. Insulin resistance in Rheumatoid arthritis: Disease-related indicators and associations with the presence and progression of subclinical atherosclerosis.Arthritis Rheumatol.201567362663610.1002/art.3898625504899
     [Google Scholar]
  72. MovahediM. BeauchampM.E. AbrahamowiczM. RayD.W. MichaudK. PedroS. DixonW.G. Risk of incident diabetes mellitus associated with the dosage and duration of oral glucocorticoid therapy in patients with Rheumatoid arthritis.Arthritis Rheumatol.20166851089109810.1002/art.3953726663814
     [Google Scholar]
  73. SchmittJ. SchwarzK. BaurechtH. HotzeM. Fölster-HolstR. RodríguezE. LeeY.A.E. FrankeA. DegenhardtF. LiebW. GiegerC. KabeschM. NöthenM.M. IrvineA.D. McLeanW.H.I. DeckertS. StephanV. SchwarzP. AringerM. NovakN. WeidingerS. Atopic dermatitis is associated with an increased risk for Rheumatoid arthritis and inflammatory bowel disease, and a decreased risk for type 1 diabetes.J. Allergy Clin. Immunol.2016137113013610.1016/j.jaci.2015.06.02926253344
     [Google Scholar]
  74. DesseinP.H. JoffeB.I. StanwixA.E. ChristianB.F. VellerM. Glucocorticoids and insulin sensitivity in Rheumatoid arthritis.J. Rheumatol.200431586787415124244
     [Google Scholar]
  75. NgC.Y.H. TayS.H. McIntyreR.S. HoR. TamW.W.S. HoC.S.H. Elucidating a bidirectional association between Rheumatoid arthritis and depression: A systematic review and meta-analysis.J. Affect. Disord.202231140741510.1016/j.jad.2022.05.10835642835
     [Google Scholar]
  76. AnderssonN.W. GustafssonL.N. OkkelsN. TahaF. ColeS.W. Munk-JørgensenP. GoodwinR.D. Depression and the risk of autoimmune disease: A nationally representative, prospective longitudinal study.Psychol. Med.201545163559356910.1017/S003329171500148826271451
     [Google Scholar]
  77. MatchamF. RaynerL. SteerS. HotopfM. The prevalence of depression in Rheumatoid arthritis: A systematic review and meta-analysis.Rheumatology201352122136214810.1093/rheumatology/ket16924003249
     [Google Scholar]
  78. MaldonadoG. Depression in Rheumatoid arthritis.Revista Colombiana de Reumatología2017242849110.1016/j.rcreu.2016.12.001
     [Google Scholar]
  79. ZhouT. SunJ. TangL. YuanY. WangJ. ZhangL. Potential diagnostic markers and therapeutic targets for Rheumatoid arthritis with comorbid depression based on bioinformatics analysis.Front. Immunol.202314100762410.3389/fimmu.2023.100762436911710
     [Google Scholar]
  80. MillerA.H. MaleticV. RaisonC.L. Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression.Biol. Psychiatry200965973274110.1016/j.biopsych.2008.11.02919150053
     [Google Scholar]
  81. NerurkarL. SiebertS. McInnesI.B. CavanaghJ. Rheumatoid arthritis and depression: An inflammatory perspective.Lancet Psychiatry20196216417310.1016/S2215‑0366(18)30255‑430366684
     [Google Scholar]
  82. JiangW. WangX. TaoD. ZhaoX. Identification of common genetic characteristics of Rheumatoid arthritis and major depressive disorder by bioinformatics analysis and machine learning.Front. Immunol.202314118311510.3389/fimmu.2023.118311537415981
     [Google Scholar]
  83. WeissmanM.M. BlandR.C. CaninoG.J. FaravelliC. GreenwaldS. HwuH.G. JoyceP.R. Karame.g. LeeC.K. LellouchJ. LépineJ.P. NewmanS.C. Rubio-StipecM. WellsJ.E. WickramaratneP.J. WittchenH. YehE.K. Cross-national epidemiology of major depression and bipolar disorder.JAMA1996276429329910.1001/jama.1996.035400400370308656541
     [Google Scholar]
  84. DorwartR. Pigmented villonodular synovitis of synovial joints: Clinical, pathologic, and radiologic features.AJR Am J Roentgenol2012143487788510.2214/ajr.143.4.877
     [Google Scholar]
  85. FinisK. SültmannH. RuschhauptM. BunessA. HelmchenB. KunerR. GrossM.L. FinkB. SchirmacherP. PoustkaA. BergerI. Analysis of pigmented villonodular synovitis with genome-wide complementary DNA microarray and tissue array technology reveals insight into potential novel therapeutic approaches.Arthritis Rheum.20065431009101910.1002/art.2164116508983
     [Google Scholar]
  86. ChebibI. ChangC.Y. SchwabJ.H. KerrD.A. DeshpandeV. NielsenG.P. Histopathology of synovial cysts of the spine.Histopathology201872692392910.1111/his.1346529314220
     [Google Scholar]
  87. CuppJ.S. MillerM.A. MontgomeryK.D. NielsenT.O. O’ConnellJ.X. HuntsmanD. RijnM. GilksC.B. WestR.B. Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, Rheumatoid arthritis and other reactive synovitides.Am. J. Surg. Pathol.200731697097610.1097/PAS.0b013e31802b86f817527089
     [Google Scholar]
  88. HengH. LiD. SuW. LiuX. YuD. BianZ. LiJ. Exploration of comorbidity mechanisms and potential therapeutic targets of Rheumatoid arthritis and pigmented villonodular synovitis using machine learning and bioinformatics analysis.Front. Genet.202313109505810.3389/fgene.2022.109505836685864
     [Google Scholar]
  89. CedergrenJ. ForslundT. SundqvistT. SkoghT. Intracellular oxidative activation in synovial fluid neutrophils from patients with Rheumatoid arthritis but not from other arthritis patients.J. Rheumatol.200734112162217017937476
     [Google Scholar]
  90. BergerI. WeckaufH. HelmchenB. EhemannV. PenzelR. FinkB. BerndL. AutschbachF. Rheumatoid arthritis and pigmented villonodular synovitis: comparative analysis of cell polyploidy, cell cycle phases and expression of macrophage and fibroblast markers in proliferating synovial cells.Histopathology200546549049710.1111/j.1365‑2559.2005.01959.x15842630
     [Google Scholar]
  91. MurpheyM. D. RheeJ. H. LewisR. B. Fanburg-SmithJ. C. FlemmingD. J. WalkerE. A. Pigmented villonodular synovitis: Radiologic-pathologic correlation.Radiographics20082851493151810.1148/rg.285085134
     [Google Scholar]
  92. DerksenV.F.A.M. HuizingaT.W.J. van der WoudeD. The role of autoantibodies in the pathophysiology of Rheumatoid arthritis.Semin. Immunopathol.201739443744610.1007/s00281‑017‑0627‑z28451788
     [Google Scholar]
  93. MichaudK. WolfeF. Comorbidities in Rheumatoid arthritis.Best Pract. Res. Clin. Rheumatol.200721588590610.1016/j.berh.2007.06.00217870034
     [Google Scholar]
  94. OttmanR. LiptonR.B. EttingerA.B. CramerJ.A. ReedM.L. MorrisonA. WanG.J. Comorbidities of epilepsy: Results from the Epilepsy Comorbidities and Health (EPIC) survey.Epilepsia201152230831510.1111/j.1528‑1167.2010.02927.x21269285
     [Google Scholar]
  95. ZhaoH. LiS. XieM. ChenR. LuH. WenC. FilianoA.J. XuZ. Risk of epilepsy in Rheumatoid arthritis: A meta-analysis of population based studies and bioinformatics analysis.Ther. Adv. Chronic Dis.202011204062231989930010.1177/204062231989930032095225
     [Google Scholar]
  96. RomA.L. WuC.S. OlsenJ. JawaheerD. HetlandM.L. ChristensenJ. OttesenB. MørchL.S. Parental Rheumatoid arthritis and childhood epilepsy.Neurology201687242510251610.1212/WNL.000000000000342427856781
     [Google Scholar]
  97. RanaA. MustoA. E. The role of inflammation in the development of epilepsy.J Neuroinflammation201815114410.1186/s12974‑018‑1192‑7
     [Google Scholar]
  98. ChangK.H. HsuY.C. ChangM.Y. LinC.L. WuT.N. HwangB.F. ChenC.Y. LiuH.C. KaoC.H. A large-scale study indicates increase in the risk of epilepsy in patients with different risk factors, including Rheumatoid arthritis.Medicine20159436e148510.1097/MD.000000000000148526356713
     [Google Scholar]
  99. MalekpourM. SalarikiaS.R. KashkooliM. Asadi-PooyaA.A. The genetic link between systemic autoimmune disorders and temporal lobe epilepsy: A bioinformatics study.Epilepsia Open20238250951610.1002/epi4.1272736929812
     [Google Scholar]
  100. DupuisN. AuvinS. Inflammation and epilepsy in the developing brain: clinical and experimental evidence.CNS Neurosci. Ther.201521214115110.1111/cns.1237125604829
     [Google Scholar]
/content/journals/crr/10.2174/0115733971302188240515075547
Loading
A Review of Connecting Bioinformatic Techniques to Rheumatoid Arthritis and its Associated Comorbidities
Curr. Rheumatol. Rev. 21, 25 (2025); https://doi.org/10.2174/0115733971302188240515075547
/content/journals/crr/10.2174/0115733971302188240515075547
/content/journals/crr/10.2174/0115733971302188240515075547
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): bioinformatic techniques, autoimmune; comorbid diseases; genes; pathways; Rheumatoid arthritis

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test